Statins the HMG-CoA reductase inhibitors in perspective

Statins the HMG-CoA reductase inhibitors in perspective

What is a statin? It is the most powerful lipid-lowering agent yet produced. Its main action is to lower the low-density lipoprotein (LDL) cholesterol level, thereby reducing the overall cholesterol level in the blood. In this new edition of this popular book, the authors examine the existing and em...

Full description

Saved in:
Bibliographic Details
Other Authors: Packard, Christopher J. (Editor), Shepherd, J. 1944- (Editor), Gaw, Allan (Editor)
Format: Book
Language:English
Published: London New York Independence, KY Martin Dunitz Distributed in the USA by Taylor & Francis 2004
Edition:Second Editiion
Subjects:
Hyperlipidemia
Antilipemic agents
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000n a2200000 a 4501
001 wils-312564
005 2023612111417
008 230712t2004 -UK a# #001 deng D
020 # # |a 9781841842929  |q hardback 
020 # # |a 1841842923  |q hardback 
040 # # |a UiTM  |e rda 
041 0 # |a English 
060 0 0 |a QU 85 
090 0 0 |a QU85  |b S797 2004 
245 0 0 |a Statins  |b the HMG-CoA reductase inhibitors in perspective  |c edited by Allan Gaw, Christopher J. Packard, James Shepherd 
250 # # |a Second Editiion 
264 # 1 |a London  |a New York  |a Independence, KY  |b Martin Dunitz  |b Distributed in the USA by Taylor & Francis  |c 2004 
264 # 4 |c ©2004 
300 # # |a viii, 262 pages  |b illustrations  |c 26 cm 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a unmediated  |b n  |2 rdamedia 
338 # # |a volume  |b nc  |2 rdacarrier 
504 # # |a Includes bibliographical references and index 
520 # # |a What is a statin? It is the most powerful lipid-lowering agent yet produced. Its main action is to lower the low-density lipoprotein (LDL) cholesterol level, thereby reducing the overall cholesterol level in the blood. In this new edition of this popular book, the authors examine the existing and emerging statins and their beneficial effectiveness in reducing serum cholesterol. New chapters cover combination therapy in lipid-lowering, new 'Megatrials' (HPS and PPP) and the PROSPER study. Also presented are the effects of statins on non-vascular conditions such as osteoporosis, cancer, dementia and diabetes 
650 1 2 |a Hyperlipidemia 
650 2 2 |a Antilipemic agents 
700 1 # |a Packard, Christopher J.  |e editor 
700 1 # |a Shepherd, J.  |d 1944-  |e editor 
700 1 # |a Gaw, Allan  |e editor 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=312564 
964 # # |c BOK  |d 01 
998 # # |a 00250##a006.2.2||00250##b006.2.2||00264#1a006.2.2||00264#1a002.8.2||00264#1a002.8.2||00264#1b006.2.2||00264#1b002.8.4||00300##a006.2.2||00300##b006.2.2||00300##c006.2.2||00520##a006.2.2||00520##b006.2.2|| 

Similar Items